DUBLIN–(BUSINESS WIRE)–The “Global COPD & Asthma Diagnostic and Monitoring Devices Market, by Product Type, by Indication, by End-user, Estimation & Forecast, 2017-2030” report has been added to ResearchAndMarkets.com’s offering.
The global COPD & asthma diagnostic and monitoring devices market held a market value of USD 6,696.41 million in 2021 and is estimated to reach USD 13,971.38 million by the year 2030. The market is likely to register a CAGR of 8.45% during the forecast period. In addition to that, the market volume is estimated to account for 88.45 million units in 2021, with a growth rate of 6.18% over the anticipated period.
With ever-increasing burden of diseases, coupled with the pandemic outbreak, the demand for asthma and COPD monitoring and diagnostic devices has been tremendously rising. Moreover, the exposure to environment pollution is also a factor boosting the demand. Furthermore, the portability of the drug delivery devices and the technological advancements drive the growth of the industry.
On the other hand, the strict regulatory framework hinders the growth of the industry. In addition to that, the high cost of the device is another factor hampering the preference rate of the COPD and asthma monitoring and diagnostic devices. Moreover, the product recalls also hinder the growth rate of the industry. For instance, in August 2022, Philips expanded an earlier announced recall of respiratory machines to a total of 1,700 devices globally owing toa possible contamination of a plastic component with a non-compatible material.
Growth Influencers:
Portability of the Drug Delivery Devices
The prominent players in the market are focusing on developing drug delivery devices that are portable, disposable, and provide other benefits. For instance, in September 2021, BreatheSuite received FDA 510 (k) clearance for its BreatheSuite metered-dose inhaler (MDI) V1 device.
BreatheSuite designed the device to turn existing MDIs into smart inhalers by automatically monitoring and offering feedback on inhaler adherence and technique for people with asthma and COPD. It constitutes a disposable, battery-powered, portable MDI add-on and a mobile application based on behaviour change strategies. Thus, such new releases boost the growth rate of the market.
Increase in population of active smokers
The rise in active smoker population drives the growth rate of the COPD and asthma diagnostic and monitoring devices industry. For instance, cigarette smoking prevails as the leading cause of preventable disease, and death in the United States, and the Office on Smoking and Health, National Center for Chronic Disease Prevention and Health Promotion mentions that it accounts for more than 480,000 deaths every year. Thus, such high statistics boost the demand in the market.
Segments Overview:
The global COPD & asthma diagnostic and monitoring devices market is segmented into product type, indication, and end user.
By Product Type
Diagnostic Devices
Spirometers
Electrocardiograms
FeNO Test analyzer
Arterial blood gas analyzer (ABG)
Polysomnography devices
Peak flow meters
Others
Monitoring Devices
Pulse oximeters
Capnographs
Asthma monitors
Portable tabletop pulse oximeter
Wearable devices
Fourier transform infrared spectroscopy (FTIR)
Others
Consumables & Accessories
Masks
Spirometry accessories
Polysomnography accessories
Peak flow meter accessories
Pulse oximeter sensors
Capnography accessories
Gas analyzer accessories
Others
By Indication
Asthma
COPD
By End User
Hospitals and clinics
Home care settings
Others
The hospitals and clinics segment held the highest market share of more than 60% in 2021, with the highest growth rate of 8.76%.
Key Topics Covered:
Chapter 1. Research Framework
Chapter 2. Research Methodology
Chapter 3. Executive Summary: Global COPD & Asthma Diagnostic and Monitoring Devices Market
Chapter 4. Global COPD & Asthma Diagnostic and Monitoring Devices Market Overview
Chapter 5. COPD & Asthma Diagnostic and Monitoring Devices Market Analysis, by Product
Chapter 6. COPD & Asthma Diagnostic and Monitoring Devices Market Analysis, by Indication
Chapter 7. COPD & Asthma Diagnostic and Monitoring Devices Market Analysis, by End User
Chapter 8 COPD & Asthma Diagnostic and Monitoring Devices Market Analysis, By Region
Chapter 9. Company Profiles
Companies Mentioned
Becton Dickinson And Company
Dragerwerk Ag & Co. KGAA
Getinge AB
Invacare Corporation
Masimo Corporation
Medtronic Plc
Nihon Kohden Corporation
Smiths Medical
Vyaire Medical
For more information about this report visit https://www.researchandmarkets.com/r/7a1moq
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
